Autolus Therapeutics (AUTL) Gains from Sales and Divestitures (2020)
Autolus Therapeutics posted quarterly Gains from Sales and Divestitures of -$160000.0 for Q3 2020, little changed on a QoQ basis from -$160000.0 in Q2 2020.
Autolus Therapeutics (AUTL) has 1 years of Gains from Sales and Divestitures data on file, last reported at -$160000.0 in Q3 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Autolus Therapeutics | - | - | -1.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | -160,000.00 |
| Sep 30, 2020 | -160,000.00 |
| Jun 30, 2020 | -160,000.00 |
| Jun 30, 2020 | -160,000.00 |
| Mar 31, 2020 | -160,000.00 |
| Mar 31, 2020 | -160,000.00 |